Literature DB >> 14513240

[Systemic therapy of atopic dermatitis].

A Heratizadeh1, K Breuer, A Kapp, T Werfel.   

Abstract

The optimal treatment of atopic dermatitis requires regular medical supervision. The course of this chronic skin disease is influenced by multiple triggers which are relevant for the treatment. The mainstays of topical therapy include regular use of emollients coupled with antimicrobial substances, corticosteroids and immune modulators as required. Ultraviolet radiation and immunosuppressive regimens represent further options for the treatment of severe exacerbations and may lead to long term improvement. Data from experimental studies provide insight into possible future treatment methods.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513240     DOI: 10.1007/s00105-003-0605-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  54 in total

Review 1.  FK506 and cyclosporin, molecular probes for studying intracellular signal transduction.

Authors:  J Liu
Journal:  Immunol Today       Date:  1993-06

2.  Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.

Authors:  J Berth-Jones; R A Graham-Brown; R Marks; R D Camp; J S English; K Freeman; C A Holden; S C Rogers; S Oliwiecki; P S Friedmann; M S Lewis-Jones; C B Archer; B Adriaans; W S Douglas; B R Allen
Journal:  Br J Dermatol       Date:  1997-01       Impact factor: 9.302

3.  Successful monotherapy of severe and intractable atopic dermatitis by photopheresis.

Authors:  H I Richter; C Billmann-Eberwein; M Grewe; H Stege; M Berneburg; T Ruzicka; J Krutmann
Journal:  J Am Acad Dermatol       Date:  1998-04       Impact factor: 11.527

4.  [Characterization of nonresponders in high dosage UVA1 therapy of acute exacerbated atopic dermatitis].

Authors:  C M Schempp; T Effinger; W Czech; J Krutmann; J C Simon; E Schöpf
Journal:  Hautarzt       Date:  1997-02       Impact factor: 0.751

5.  Adrenal function following topical steroid treatment in children with atopic dermatitis.

Authors:  L Patel; P E Clayton; G M Addison; D A Price; T J David
Journal:  Br J Dermatol       Date:  1995-06       Impact factor: 9.302

6.  A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis.

Authors:  A Y Fung; P C Look; L Y Chong; P P But; E Wong
Journal:  Int J Dermatol       Date:  1999-05       Impact factor: 2.736

Review 7.  A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis.

Authors:  S Jolles
Journal:  Clin Exp Dermatol       Date:  2002-01       Impact factor: 3.470

8.  Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.

Authors:  J Berth-Jones; A Takwale; E Tan; G Barclay; S Agarwal; I Ahmed; K Hotchkiss; R A C Graham-Brown
Journal:  Br J Dermatol       Date:  2002-08       Impact factor: 9.302

9.  Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment.

Authors:  E Stockfleth; C Ulrich; T Meyer; E Christophers
Journal:  Recent Results Cancer Res       Date:  2002

10.  Local steroid therapy and bacterial skin flora in atopic dermatitis.

Authors:  J F Stalder; M Fleury; M Sourisse; M Rostin; F Pheline; P Litoux
Journal:  Br J Dermatol       Date:  1994-10       Impact factor: 9.302

View more
  2 in total

1.  [Local antibiotics or antiseptics in combination with glucocorticoids].

Authors:  S Melhorn
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

Review 2.  [Antimicrobially effective compounded medications. Clinical value and critical comments].

Authors:  R Eifler-Bollen; J W Fluhr
Journal:  Hautarzt       Date:  2005-08       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.